Cosmos Health (COSM) Stock Price, News & Analysis

Company Overview

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Key Stats

• Today's Range: $0.58 to $0.65
• 50-Day Range: $0.58 to $0.82
• 52-Week Range: $0.47 to $1.65
• Volume: 160,457 shs
• Average Volume: 786,684 shs
• Market Capitalization: $13.56 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Cosmos Health Stock Analysis - MarketRank™

Cosmos Health scored higher than 7% of companies evaluated by MarketBeat, and ranked 879th out of 947 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cosmos Health.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Cosmos Health are expected to grow in the coming year, from ($0.78) to $0.01 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cosmos Health is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cosmos Health is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Cosmos Health has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.35% of the float of Cosmos Health has been sold short.

Short Interest Ratio / Days to Cover

Cosmos Health has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cosmos Health has recently increased by 24.10%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cosmos Health does not currently pay a dividend.

Dividend Growth

Cosmos Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.35% of the float of Cosmos Health has been sold short.

Short Interest Ratio / Days to Cover

Cosmos Health has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cosmos Health has recently increased by 24.10%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for COSM on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Cosmos Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cosmos Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

15.61% of the stock of Cosmos Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 12.61% of the stock of Cosmos Health is held by institutions.

COSM Stock Analysis - Frequently Asked Questions

How have COSM shares performed this year?

Cosmos Health's stock was trading at $1.41 at the start of the year. Since then, COSM stock has decreased by 58.7% and is now trading at $0.5829.
View the best growth stocks for 2024 here.

When did Cosmos Health's stock split?

Cosmos Health shares reverse split before market open on Thursday, December 15th 2022. The 1-25 reverse split was announced on Thursday, December 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of Cosmos Health?

Shares of COSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Cosmos Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cosmos Health investors own include Meta Platforms (META), NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET) and Builders FirstSource (BLDR).

Company Calendar

• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Drugs, proprietaries, & sundries
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:COSM
• CUSIP: N/A
• CIK: 1474167
• Web: www.cosmosholdingsinc.com
• Phone: (312) 536-3102
• Fax: N/A
• Employees: 123
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.44)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-18,540,000.00
• Net Margins: -36.39%
• Pretax Margin: -36.39%
• Return on Equity: -9.39%
• Return on Assets: -5.10%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 1.44
• Quick Ratio: 1.24

Sales & Book Value

• Annual Sales: $56.04 million
• Price / Sales: 0.24
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.13 per share
• Price / Book: 0.27

Miscellaneous

• Outstanding Shares: 23,260,000
• Free Float: 19,629,000
• Market Cap: $13.56 million
• Optionable: Optionable
• Beta: 5.56